IP Library Granted Patent US 7,087,387
Granted Patent B2
US 7,087,387 · App. 10/690,359 · Granted Aug 8, 2006

Nucleic acid archiving

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,087,387
App. No.
10/690,359
Granted
Aug 8, 2006
Kind
B2
Abstract

This invention provides a kit comprising a substrate having a surface coated with a solid phase matrix for nucleic acid manipulation. The solid phase matrix exhibits sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids in a sample. The manipulations include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method for virus extraction, purification, and solid phase amplification from large volume plasma specimens is described.

Claims (11)

1. A kit for nucleic acid manipulation, comprising:

(a) a substrate having a surface coated with a solid phase matrix, wherein said matrix is a specific binding material having one or more electropositive materials rendered hydrophilic; and

(b) one or more containers comprising buffers and/or reagents necessary for manipulating said nucleic acid.

2. The kit of claim 1 , wherein said substrate is in the shape of tubes, plates, membranes, capillaries, slides beads, microparticles, fibers, microchannels, and microarrays.

3. The kit of claim 1 , wherein said substrate is a polymer or an oxide substrate.

4. The kit of claim 1 , wherein said electropositive material comprises one or more elements selected from the group consisting of aluminum, titanium, zirconium, hafnium, scandium, yttrium, lanthanum, vanadium, tantalum, chromium, molybdenum, tungsten, boron, gallium, indium, germanium, tin, and lead.

5. The kit of claim 1 , wherein said matrix is selected from the group consisting of aluminum oxide, titanium oxide (Ti 2 O 3 ), and modified zirconium dioxide (ZrO 2 ).

6. The kit of claim 1 , wherein said matrix is selected from the group consisting of alpha aluminum oxide, gamma aluminum oxide and an aluminum oxide thin-film of mixed composition.

7. The kit of claim 1 , wherein said solid phase matrix is titanium oxide (Ti 2 O 3 ).

8. The kit of claim 1 , wherein said solid phase matrix is modified zirconium oxide (ZrO 2 ).

9. The kit of claim 1 , wherein said reagents include reagents for amplifying said nucleic acid.

Assignments (4)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →